{
  "meta": {
    "title": "45_Hypothalamus_And_Pituitary",
    "url": "https://brainandscalpel.vercel.app/45-hypothalamus-and-pituitary-d1228bdf.html",
    "scrapedAt": "2025-11-30T12:34:29.842Z"
  },
  "questions": [
    {
      "text": "You decide to start recombinant growth hormone therapy in a child with idiopathic short stature. The treatment primarily works by the activation of which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "G protein coupled receptors"
        },
        {
          "id": 2,
          "text": "JAK/STAT pathway"
        },
        {
          "id": 3,
          "text": "Nuclear receptors"
        },
        {
          "id": 4,
          "text": "PI3/Akt pathway"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Growth hormone</strong>&nbsp;primarily acts through activation of the&nbsp;<strong>JAK-STAT</strong>&nbsp;signaling pathway.</p>\n<p>Cytokines such as<strong> interferon-gamma</strong> and&nbsp;<strong>prolactin</strong>&nbsp;hormone also act by the&nbsp;<strong>JAK STAT pathway.</strong></p><hr><h3>Related Pearl: Mechanisms of Action of Hormones</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Types of hormone receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to intracellular receptors</strong></td>\n</tr>\n<tr>\n<td rowspan=\"3\">Cytoplasmic receptors</td>\n<td>Glucocorticoids</td>\n</tr>\n<tr>\n<td>Mineralocorticoids</td>\n</tr>\n<tr>\n<td>Androgens</td>\n</tr>\n<tr>\n<td> </td>\n<td>Vitamin D</td>\n</tr>\n<tr>\n<td rowspan=\"2\">Nuclear receptors</td>\n<td>Thyroid hormones</td>\n</tr>\n<tr>\n<td>Vitamins A</td>\n</tr>\n<tr>\n<td colspan=\"2\"><strong>Hormones that bind to cell surface receptors</strong></td>\n</tr>\n<tr>\n<td colspan=\"2\">1. <strong>G-protein coupled receptors</strong> (GPCR)</td>\n</tr>\n<tr>\n<td rowspan=\"9\"><strong>Gs</strong>: stimulation of second messenger cAMP</td>\n<td>ACTH, CRH</td>\n</tr>\n<tr>\n<td>TSH, GHRH</td>\n</tr>\n<tr>\n<td>FSH, LH, hCG</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Catecholamines (β receptors)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td>Glucagon</td>\n</tr>\n<tr>\n<td>Secretin</td>\n</tr>\n<tr>\n<td>Parathyroid hormone</td>\n</tr>\n<tr>\n<td rowspan=\"3\"><strong>Gi: </strong>inhibition of second messenger cAMP</td>\n<td>Catecholamines (ɑ<sub>2</sub> receptors)</td>\n</tr>\n<tr>\n<td>Acetylcholine (M2, M4)</td>\n</tr>\n<tr>\n<td>Somatostatin</td>\n</tr>\n<tr>\n<td rowspan=\"11\">\n<p><strong>Gq</strong>: second messenger is phospholipase C or cGMP</p>\n</td>\n<td><strong>Phospholipase C (IP3 DAG pathway):</strong></td>\n</tr>\n<tr>\n<td>GnRH, GHRH, TRH</td>\n</tr>\n<tr>\n<td>Catecholamines (ɑ<sub>1</sub> receptors)</td>\n</tr>\n<tr>\n<td>Vasopressin (V<sub>1</sub> receptor)</td>\n</tr>\n<tr>\n<td>Gastrin</td>\n</tr>\n<tr>\n<td>Cholecystokinin</td>\n</tr>\n<tr>\n<td>Oxytocin</td>\n</tr>\n<tr>\n<td>Acetylcholine (M1, M3, M5)</td>\n</tr>\n<tr>\n<td><strong>cGMP:</strong></td>\n</tr>\n<tr>\n<td>Atrial natriuretic peptide</td>\n</tr>\n<tr>\n<td>Nitric oxide</td>\n</tr>\n<tr>\n<td colspan=\"2\">2. <strong>Tyrosine kinase</strong> receptors</td>\n</tr>\n<tr>\n<td rowspan=\"5\">Through the <strong>JAK-STAT</strong> (non-receptor tyrosine kinase) or <strong>MAP kinase</strong> (receptor tyrosine kinase) pathway </td>\n<td>Growth factors like IGF, VEGF, FGF, PDGF</td>\n</tr>\n<tr>\n<td>Growth hormone</td>\n</tr>\n<tr>\n<td>Erythropoietin</td>\n</tr>\n<tr>\n<td>Insulin</td>\n</tr>\n<tr>\n<td>Prolactin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Notes: <br />1. Even though the cytoplasmic receptors are present in the cytoplasm, once the <strong>hormone-receptor complex</strong> is formed it moves to the <strong>nucleus</strong> for its actions.</p>\n<p>2. <strong>Vitamin D</strong> is a <strong>cytoplasmic receptor.</strong> All intracellular receptors are inherently nuclear receptors as they bind and get activated at the nucleus as mentioned above but they have two sites of primary action- cytoplasm and nucleus. </p>\n<p>3. While receptor tyrosine kinases have intrinsic tyrosine kinase activity, non-receptor tyrosine kinases have an external tyrosine kinase component that interacts with the receptor as and when required. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0927",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions is growth hormone therapy not indicated?",
      "choices": [
        {
          "id": 1,
          "text": "Turner syndrome"
        },
        {
          "id": 2,
          "text": "Prader Willi syndrome"
        },
        {
          "id": 3,
          "text": "Sotos syndrome"
        },
        {
          "id": 4,
          "text": "Noonan syndrome"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Growth hormone therapy is <strong>not indicated</strong> in <strong>Sotos syndrome.</strong></p>\n<p dir=\"auto\">Indications for GH therapy are:</p>\n<ul>\n<li dir=\"auto\">GH Deficiency in children &amp; adults</li>\n<li dir=\"auto\">AIDS-associated wasting</li>\n<li dir=\"auto\">Malabsorption associated with the short-bowel syndrome (As GH stimulates the adaptation of GI epithelial cells).</li>\n<li dir=\"auto\">Children with other conditions associated with short stature despite adequate GH production:<br />\n<ul>\n<li dir=\"auto\">Turner syndrome</li>\n<li dir=\"auto\">Noonan syndrome</li>\n<li dir=\"auto\">Prader-Willi syndrome</li>\n<li dir=\"auto\">Chronic renal insufficiency</li>\n<li dir=\"auto\">Small for gestational age babies</li>\n<li dir=\"auto\">Idiopathic short stature</li>\n</ul>\n</li>\n</ul>\n<p>Sotos syndrome (cerebral gigantism) is characterized by excessive physical growth during the first few years of life resulting in a disproportionately <strong>large and long head</strong> with a slightly protrusive forehead,&nbsp;<strong>large hands and feet</strong>, hypertelorism, and down-slanting eyes. It is accompanied by mild cognitive impairment, developmental abnormalities, hypotonia, and speech abnormalities.</p>\n<p>The image given below shows a large head, large hands, and characteristic eye features in a child with Sotos syndrome.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5abbb04bf06249f0a95cb0f7ff0a978ax440x704.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3522",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are sound advice to the respective patients except:<div class='question-desc-html'><ol>\n<li>A 5-year-old child is advised to undergo fundoscopic examination before the initiation of GH therapy</li>\n<li>A 7-year-old child on GH therapy is advised periodic fundoscopic examination</li>\n<li>An 8-year-old child on GH therapy is advised periodic fasting glucose monitoring</li>\n<li>A 17-year-old female who was receiving GH therapy and is now starting OCPs is prescribed an increased GH dose</li>\n<li>A 7-year-old child with leukemia who has recently gone into remission is advised to defer GH therapy for 3 years</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 5"
        },
        {
          "id": 2,
          "text": "only 5"
        },
        {
          "id": 3,
          "text": "2 and 4"
        },
        {
          "id": 4,
          "text": "3, 4 and 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p dir=\"auto\"><strong>GH deferral </strong>is only recommended for the <strong>first year </strong>after treatment of leukemia.&nbsp;</p>\n<p dir=\"auto\">Because of the anti-insulin action of GH, there is an increased incidence of <strong>type 2 diabetes mellitus </strong>and therefore, fasting glucose levels should be monitored periodically during GH therapy.&nbsp;Due to the rare potential for developing <strong>intracranial hypertension</strong>, fundoscopic examination is recommended at the initiation of therapy and at periodic intervals thereafter. Rapid growth induced by GH can cause slipped epiphyses or scoliosis in children.</p>\n<p dir=\"auto\">Estrogens (OCPs and estrogen supplements) inhibit GH action so that a larger dose is needed to <strong>maintain </strong>the same<strong> IGF-1 level.</strong></p>\n<p>The adverse effects of growth hormone are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Children</strong></td>\n<td><strong>Adults</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li><strong>Intracranial hypertension&nbsp;</strong></li>\n<li>Increased risk of <strong>type 2 diabetes</strong></li>\n<li>Slipped epiphysis&nbsp;</li>\n<li>Scoliosis</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Peripheral edema</li>\n<li>Carpal tunnel syndrome</li>\n<li>Arthralgias</li>\n<li>Myalgia</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9116",
      "difficulty": "medium"
    },
    {
      "text": "A middle-aged man with tall stature, frontal bossing, prognathism, large hands, and feet is started on a growth hormone receptor antagonist. Identify the drug.",
      "choices": [
        {
          "id": 1,
          "text": "Octreotide"
        },
        {
          "id": 2,
          "text": "Lanreotide"
        },
        {
          "id": 3,
          "text": "Pegvisomant"
        },
        {
          "id": 4,
          "text": "Cabergoline"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario depicts acromegaly.&nbsp;<strong>Pegvisomant</strong> is a <strong>growth hormone receptor antagonist</strong>&nbsp;that is indicated for the treatment of <strong>acromegaly.</strong></p>\n<p><strong>Octreotide</strong> and<strong> lanreotide</strong> are synthetic&nbsp;<strong>somatostatin analogs</strong>&nbsp;that can be used in the management of acromegaly.</p>\n<p><strong>Cabergoline</strong> is a <strong>dopamine agonist</strong> used primarily to treat hyperprolactinemia also has an indication in the management of acromegaly.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9127",
      "difficulty": "easy"
    },
    {
      "text": "A 23-year-old lady presented to the gynecology OPD with complaints of amenorrhea and milky discharge from her breasts. Her urine pregnancy test is negative and her serum prolactin level is 175 µg/L. The resident prescribes a long-acting D2 agonist. Which of the following drugs is she likely to have been prescribed?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Lisuride"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Apomorphine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario depicts <strong>hyperprolactinemia</strong>. Cabergoline is a&nbsp;<strong>long-acting D2 agonist. </strong></p>\n<p>Its<strong>&nbsp;</strong>t1/2 is &gt;60 hours. It is indicated for the treatment of <strong>hyperprolactinemia</strong> and acromegaly.</p>\n<p>Bromocriptine, lisuride, and apomorphine are <strong>short-acting</strong> when compared with cabergoline.</p>\n<p><strong>Bromocriptine</strong> is an ergot alkaloid derivative used in the management of type 2 diabetes mellitus, hyperprolactinemia, acromegaly, and Parkinson's disease.&nbsp;Cabergoline is preferred over bromocriptine for hyperprolactinemia due to lower adverse effects such as nausea and also due to dosing advantage (twice a week instead of daily dosing).</p>\n<p><strong>Lisuride</strong> is indicated in <strong>early Parkinson's disease</strong> but is also known to decrease prolactin levels and prevent migraine attacks.&nbsp;<strong>Apomorphine</strong>&nbsp;is a morphine derivative used to treat hypomobile <strong>\"off\" episodes</strong> of advanced Parkinson's disease.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9167",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following conditions is octreotide not used?",
      "choices": [
        {
          "id": 1,
          "text": "Glucagonoma"
        },
        {
          "id": 2,
          "text": "Insulinoma"
        },
        {
          "id": 3,
          "text": "Short bowel syndrome"
        },
        {
          "id": 4,
          "text": "Glioma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Octreotide is not used in <strong>glioma</strong>.</p>\n<p>Uses of octreotide are :</p>\n<ol>\n<li>Secretory diarrhea in<strong>&nbsp;</strong>carcinoid syndrome and VIPoma&nbsp;</li>\n<li><strong>Short bowel syndrome</strong>, AIDS</li>\n<li>Pituitary tumors causing acromegaly</li>\n<li>Islet cell tumors&nbsp;like <strong>glucagonoma, insulinoma</strong></li>\n<li>Acute bleeding in esophageal varices</li>\n<li>Thyrotrope adenoma</li>\n</ol>\n<p>Adverse effects include gall stones, sinus bradycardia, and conduction abnormalities. Vit B12 deficiency can occur on long term use.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9119",
      "difficulty": "medium"
    },
    {
      "text": "Valvular heart disease is not associated with the use of which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Bromocriptine"
        },
        {
          "id": 2,
          "text": "Quinagolide"
        },
        {
          "id": 3,
          "text": "Cabergoline"
        },
        {
          "id": 4,
          "text": "Pergolide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p2\"><strong>Quinagolide</strong> is not associated with valvular heart disease.</p>\n<p class=\"p2\">Quinagolide is<strong>&nbsp;</strong>a&nbsp;non-ergot D2 receptor agonist.</p>\n<p class=\"p2\">Cabergoline, Bromocriptine, and Pergolide are <strong>ergot</strong> derivatives and are <strong>associated with valvular heart disease</strong>.&nbsp;The risk of valvular heart disease from ergot therapy is associated with higher doses of the drug (necessary for Parkinson's disease treatment) but not with the lower doses used in treating hyperprolactinemia.</p>\n<p class=\"p2\">Note: Pergolide was withdrawn from the market due to reports of serious valve damage.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9130",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following patients is bromocriptine not indicated?",
      "choices": [
        {
          "id": 1,
          "text": "A 35-year-old lady with galactorrhea-amenorrhea complex"
        },
        {
          "id": 2,
          "text": "A 30-year-old male patient with acromegaly"
        },
        {
          "id": 3,
          "text": "A 23-year old lady with endogenous depression"
        },
        {
          "id": 4,
          "text": "A 45-year old parkinson's patient with type 2 diabetes mellitus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Bromocriptine is&nbsp;<strong>not indicated</strong> in <strong>endogenous depression.</strong></p>\n<p>It is a semisynthetic <strong>ergot D2 receptor agonist.</strong></p>\n<p>Uses of bromocriptine:</p>\n<ol>\n<li>Hyperprolactinemia (causing <strong>galactorrhoea, amenorrhea, </strong>or infertility in women and<strong>&nbsp;</strong>gynecomastia or infertility in men)</li>\n<li><strong>Parkinsonism</strong>&nbsp;</li>\n<li><strong>Acromegaly</strong></li>\n<li><strong>Type 2 diabetes mellitus</strong>&nbsp;</li>\n<li>Hepatic coma</li>\n<li>Supression of lactation</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9137",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old chronic alcoholic patient with a history of coronary bypass surgery presents with haematemesis to the casualty. An upper GI endoscopy shows the following finding. Which of the following drugs will you administer to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Desmopressin"
        },
        {
          "id": 2,
          "text": "Propranolol"
        },
        {
          "id": 3,
          "text": "Octreotide"
        },
        {
          "id": 4,
          "text": "Terlipressin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical history of the patient and the&nbsp;endoscopic image showing prominent cherry-red spots are suggestive of&nbsp;<strong>bleeding esophageal varices</strong>.</p>\n<p><strong>Octreotide</strong> is indicated in the treatment of <strong>acute variceal bleeding.&nbsp;</strong>It is a <strong>somatostatin&nbsp;analog</strong> that reduces azygous blood flow significantly and decreases variceal bleeding.&nbsp;</p>\n<p>Other drugs that can be used for the management of bleeding esophageal varices:</p>\n<ul>\n<li>Terlipressin</li>\n<li>Vasopressin</li>\n<li>Propranolol&nbsp;</li>\n</ul>\n<p>Option A: Desmopressin is a selective V2 receptor agonist used for central diabetes insipidus and nocturnal enuresis.&nbsp;</p>\n<p>Option B: Propranolol (non-selective beta-blocker) is used in the <strong>prophylaxis</strong> of variceal bleeding and not in its acute management.</p>\n<p>Option D: Terlipressin is a vasoconstrictor used for bleeding esophageal varices but may <strong>compromise cardiac function</strong> and <strong>induce ischemia</strong> and hence can't be used in this case.<br /><br /><br />Note: Although terlipressin is a vasoconstrictor and is be used for bleeding oesophagal varices, the patient in this scenario has a <strong>history of MI</strong> (undergone coronary bypass surgery). <strong>Terlipressin</strong> can <strong>compromise cardiac function </strong>(reduces cardiac output and ejection fraction) and <strong>induce ischemia. </strong>Hence, it is not preferred in this case.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8a0f088f40a64d359eb049aa6ff287c7.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3527",
      "difficulty": "medium"
    },
    {
      "text": "Pulsatile dosing of GnRH agonist is used for the treatment of __________.",
      "choices": [
        {
          "id": 1,
          "text": "Male infertility"
        },
        {
          "id": 2,
          "text": "Endometriosis"
        },
        {
          "id": 3,
          "text": "Precocious puberty"
        },
        {
          "id": 4,
          "text": "Prostate cancer"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pulsatile</strong> administration of GnRH agonists results in<strong> increased FSH and LH secretion</strong> and is therefore used to treat <strong>male</strong> and female <strong>infertility</strong>.</p>\n<p><strong>Non-pulsatile</strong> or <strong>continuous</strong> dose of GnRH agonist results in <strong>suppression</strong> and decreased concentrations of gonadotropins LH and FSH.&nbsp;They are used in:</p>\n<ol>\n<li><strong>Endometriosis</strong></li>\n<li>Uterine fibroids</li>\n<li><strong>Central precocious puberty</strong></li>\n<li><strong>Ca prostate</strong></li>\n<li>Ca ovary and breast</li>\n<li>Controlled ovary stimulation</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0812",
      "difficulty": "easy"
    },
    {
      "text": "A 30-year-old lady who is suffering from dysmenorrhea and infertility is diagnosed with endometriosis. She has been prescribed an intranasal spray containing a GnRH agonist. What is the likely drug?",
      "choices": [
        {
          "id": 1,
          "text": "Leuprolide"
        },
        {
          "id": 2,
          "text": "Goserelin"
        },
        {
          "id": 3,
          "text": "Histrelin"
        },
        {
          "id": 4,
          "text": "Nafarelin"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Nafarelin</strong> is a GnRH agonist administered via <strong>nasal spray.</strong></p>\n<p>It is approved for use in <strong>endometriosis</strong> and <strong>central precocious puberty.&nbsp;</strong></p>\n<p>Routes of administration of other GnRH <strong>agonists:</strong></p>\n<ul>\n<li><strong>Intranasal</strong> and subcutaneous -<strong>&nbsp;</strong>Buserelin</li>\n<li><strong>Intramuscular</strong>&nbsp;and subcutaneous -&nbsp;Leuprolide</li>\n<li>Subcutaneous implants -&nbsp;Histrelin and Goserelin</li>\n</ul>\n<p>&nbsp;Some GnRH <strong>antagonists</strong> are:</p>\n<ul>\n<li>Degarelix</li>\n<li>Ganirelix&nbsp;</li>\n<li>Cetrorelix (Synthetic)</li>\n</ul>\n<p>&nbsp;All GnRH antagonists are administered <strong>subcutaneously.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3519",
      "difficulty": "medium"
    }
  ]
}